Overview
Inventia Life Science offers scalable 3D cell culture solutions via the RASTRUM bioprinting platform, enabling reproducible, human-relevant in vitro models for drug discovery and preclinical studies. They provide Validated Solutions with predefined model blueprints, Discovery Mode for flexibility, and Discovery Services for custom indication-specific models in oncology, fibrosis, neurology, and immunology. These tools support high-throughput production, phenotypic screening, and model transfer to client sites, improving predictive power and translational relevance.
Frequently asked questions
- What 3D cell models and therapeutic areas does Inventia support?
- Inventia specializes in indication-specific models across oncology (e.g., PDAC tumor-stromal interactions), fibrosis, neurology, and immunology, using tailored extracellular matrices and cellular architectures on the RASTRUM platform.
- What products and services are available for pharma R&D teams?
- Offerings include RASTRUM Validated Solutions for predefined blueprints, Discovery Mode for custom setups, and Discovery Services for end-to-end workflows like model optimization, drug response assays, and high-content imaging, with seamless protocol transfer to clients.
- Where are Inventia Life Science's facilities located?
- Facilities are in Sydney, Australia (Suite 1.13, 100 Collins Street, Alexandria; 20-22 William Street, Alexandria) and Wilmington, Delaware, USA (200 Powder Mill Road).